Shares of Docusign Inc. (NASDAQ:DOCU – Get Free Report) gapped up before the market opened on Friday following a stronger than expected earnings report. The stock had previously closed at $76.24, but opened at $82.00. Docusign shares last traded at $80.91, with a volume of 3,022,975 shares changing hands.
The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.84 by $0.08. The company had revenue of $800.64 million for the quarter, compared to analyst estimates of $780.35 million. Docusign had a net margin of 9.08% and a return on equity of 13.98%. The business’s quarterly revenue was up 8.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.97 earnings per share. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS.
Docusign announced that its board has initiated a share repurchase plan on Thursday, June 5th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the company to reacquire up to 6.6% of its stock through open market purchases. Stock buyback plans are typically a sign that the company’s leadership believes its stock is undervalued.
Analyst Upgrades and Downgrades
View Our Latest Stock Report on Docusign
Insider Activity at Docusign
In related news, CEO Allan C. Thygesen sold 40,000 shares of the company’s stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $77.51, for a total value of $3,100,400.00. Following the completion of the sale, the chief executive officer owned 143,983 shares of the company’s stock, valued at $11,160,122.33. This represents a 21.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Robert Chatwani sold 22,875 shares of the company’s stock in a transaction dated Wednesday, June 18th. The shares were sold at an average price of $74.79, for a total transaction of $1,710,821.25. Following the completion of the sale, the insider directly owned 72,126 shares of the company’s stock, valued at $5,394,303.54. The trade was a 24.08% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 78,552 shares of company stock worth $5,983,631. 1.01% of the stock is owned by company insiders.
Institutional Investors Weigh In On Docusign
A number of institutional investors and hedge funds have recently bought and sold shares of the business. Centaurus Financial Inc. lifted its holdings in Docusign by 2.6% in the 2nd quarter. Centaurus Financial Inc. now owns 5,398 shares of the company’s stock valued at $420,000 after acquiring an additional 136 shares during the last quarter. Orion Porfolio Solutions LLC boosted its holdings in shares of Docusign by 50.8% in the second quarter. Orion Porfolio Solutions LLC now owns 23,832 shares of the company’s stock worth $1,856,000 after buying an additional 8,031 shares during the period. Neuberger Berman Group LLC boosted its holdings in shares of Docusign by 17.2% in the second quarter. Neuberger Berman Group LLC now owns 51,294 shares of the company’s stock worth $3,995,000 after buying an additional 7,511 shares during the period. B. Riley Wealth Advisors Inc. acquired a new position in shares of Docusign in the second quarter worth about $210,000. Finally, Marex Group plc acquired a new position in shares of Docusign in the second quarter worth about $386,000. 77.64% of the stock is owned by institutional investors and hedge funds.
Docusign Price Performance
The firm’s fifty day simple moving average is $75.53 and its 200 day simple moving average is $79.40. The company has a market capitalization of $16.14 billion, a price-to-earnings ratio of 60.05, a PEG ratio of 28.46 and a beta of 1.02.
Docusign Company Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Read More
- Five stocks we like better than Docusign
- About the Markup Calculator
- Why DocuSign Could Be a SaaS Value Play After Q2 Earnings
- Market Cap Calculator: How to Calculate Market Cap
- Lululemon Share Price Has Plenty of Room Left to Fall
- How to Plot Fibonacci Price Inflection Levels
- Advanced Micro Devices’ 2026 Forecasts Are Way Too Low
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.